LIMK-1/2 Polyclonal Antibody

    • 货号:YT2564
    • 应用:WB;IHC;IF;ELISA
    • 种属:Human;Mouse;Rat;Monkey
      • 靶点:
      • LIMK-1/2
      • 简介:
      • >>Axon guidance;>>Fc gamma R-mediated phagocytosis;>>Regulation of actin cytoskeleton;>>Yersinia infection;>>Human immunodeficiency virus 1 infection
      • 基因名称:
      • LIMK1/LIMK2
      • 蛋白名称:
      • LIM domain kinase 1/LIM domain kinase 2
      • 免疫原:
      • The antiserum was produced against synthesized peptide derived from human LIMK1/2. AA range:481-530
      • 特异性:
      • LIMK-1/2 Polyclonal Antibody detects endogenous levels of LIMK-1/2 protein.
      • 组成:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • 来源:
      • Polyclonal, Rabbit,IgG
      • 稀释:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
      • 纯化工艺:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • 浓度:
      • 1 mg/ml
      • 储存:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • 其他名称:
      • LIMK1;LIMK;LIM domain kinase 1;LIMK-1;LIMK2;LIM domain kinase 2;LIMK-2
      • 实测条带:
      • 72kD
      • 背景:
      • There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. LIMK1 is a serine/threonine kinase that regulates actin polymerization via phosphorylation and inactivation of the actin binding factor cofilin. This protein is ubiquitously expressed during development and plays a role in many cellular processes associated with cytoskeletal structure. This protein also stimulates axon growth and may play a role in brain development. LIMK1 hemizygosity is implicated in the impaired visuospatial constructive cog
      • 功能:
      • catalytic activity:ATP + a protein = ADP + a phosphoprotein.,disease:Haploinsufficiency of LIMK1 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in Williams-Beuren syndrome (WBS), a rare developmental disorder. It is a contiguous gene deletion syndrome involving genes from chromosome band 7q11.23.,function:Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. May be involved in brain development.,PTM:Autophosphorylated.,PTM:Phosphorylated on serine and/or threonine residues by ROCK1. May be dephosphorylated and inactivated by SSH1.,similarity:Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.,similarity:Contains 1 PDZ (DHR) doma
      • 细胞定位:
      • Cytoplasm . Nucleus . Cytoplasm, cytoskeleton . Cell projection, lamellipodium . Predominantly found in the cytoplasm. Localizes in the lamellipodium in a CDC42BPA, CDC42BPB and FAM89B/LRAP25-dependent manner. .
      • 组织表达:
      • Highest expression in both adult and fetal nervous system. Detected ubiquitously throughout the different regions of adult brain, with highest levels in the cerebral cortex. Expressed to a lesser extent in heart and skeletal muscle.
      • 产品图片
      • Western Blot analysis of various cells using LIMK-1/2 Polyclonal Antibody diluted at 1:500
      • Western Blot analysis of HEPG2 using LIMK-1/2 Polyclonal Antibody. Antibody was diluted at 1:500
      • Western Blot analysis of HEPG2 using LIMK-1/2 Polyclonal Antibody. Antibody was diluted at 1:500
      • Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue, using LIMK1/2 Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from COS7 cells, using LIMK1/2 Antibody. The lane on the right is blocked with the synthesized peptide.